High-dose versus intermediate-dose cytarabine combined with mitoxantrone for the treatment of relapsed and refractory acute myeloid leukemia: results of an age-adjusted randomized comparison

Semin Hematol. 1991 Jul;28(3 Suppl 4):35-8.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age Factors
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Cytarabine / administration & dosage
  • Dose-Response Relationship, Drug
  • Humans
  • Leukemia, Myeloid, Acute / drug therapy*
  • Middle Aged
  • Mitoxantrone / administration & dosage
  • Prospective Studies
  • Recurrence

Substances

  • Cytarabine
  • Mitoxantrone

Supplementary concepts

  • NOAC protocol